Merck Announces Initial Access Plans For Alimatravir In Low- And Middle Income Countries
MRK•Merck outlines initial access plans for Alimatravir
July 24 (Reuters) - Merck & Co Inc MRK.N:
- Plans initial Alimatravir supply pending regulatory approval, generic manufacturing ramp-up in licensed territories
- Signed non-exclusive voluntary licensing agreements with Aspen, Quality Chemical Industries & UCL Kenya for Alimatravir
- Announces initial access plans for Alimatravir in low- and middle income countries for prevention of HIV-1
- In active discussions with Fiocruz on Alimatravir availability in Latin America & Brazil
